Du Z, Pandey A, Moghadas SM, Bai Y, Wang L, Matrajt L, Singer BH, Galvani AP, Impact of RSVpreF vaccination on reducing the burden of respiratory syncytial virus in infants and older adults, Nature Medicine 2025, 1-6.
Moghadas SM, Shoukat A, Bawden CE, Langley JM, Singer BH, Fitzpatrick MC, Galvani AP. Cost-effectiveness of prefusion F protein-based vaccines against respiratory syncytial virus disease for older adults in the United States. Clinical Infectious Diseases. 2024, 78(5): 1328-1335.
Shoukat A, Abdollahi E, Galvani AP, Halperin SA, Langley JM, Moghadas SM, Cost-effectiveness analysis of nirsevimab and maternal RSVpreF vaccine strategies for prevention of respiratory syncytial virus disease among infants in Canada: A simulation study, The Lancet Regional Health - Americas 2023, 28: 100629.
Sah P, Vilches TN, Moghadas SM, Gondi S, Schneider EC, Singer J, Chokshi DA, Galvani AP, Return on investment of the COVID-19 vaccination campaign in New York City, JAMA Network Open 2022, 5(11): e2243127.
Moghadas SM, Fitzpatrick MC, Sah P, Pandey A, Shoukat A, Singer BH, Galvani AP, The implications of silent transmission for the control of COVID-19 outbreaks, Proceedings of the National Academy of Sciences USA 2020, 117(30): 17513–17515.
For citation of our published studies, visit Google Scholar
Sumsuzzman D M, Wang Z, Langley JM, Moghadas SM, Real-world effectiveness of nirsevimab against respiratory syncytial virus disease in infants: A systematic review and meta-analysis, The Lancet Child & Adolescent Health (in press).
Shi C, Ferreira SC, Maia HP, Moghadas SM, The impact of information dissemination and behavioural responses on epidemic dynamics: A multi-layer network analysis, Infectious Disease Modelling (in press).
Sumsuzzman D Md, Ye Y, Wang Z, Pandey A, Langley JM, Galvani AP, Moghadas SM, Impact of disease severity, age, sex, comorbidity, and vaccination on secondary attack rates of SARS-CoV-2: A global systematic review and meta-analysis, BMC Infectious Diseases 2025, 25, 215.
Shi C, Ferreira SC, Maia HP, Moghadas SM, Examining heterogeneity in information diffusion and its impact on disease spread in a multilayer network, Trends in Biomathematics – Springer 2025 (in press).
Shoukat A, Wells CR, Shin T, Potter-Schwartz L, Galvani AP, Moghadas SM, Assessing the impact of revising MenACWY vaccination schedule for adolescents in the United States: A modelling study, The Lancet Regional Health – Americas 2025, 44: 101033.
Ye Y, Pandey A, Bawden C, Sumsuzzman D MD, Rajput R, Shoukat A, Singer BH, Moghadas SM, Galvani AP, Integrating artificial intelligence with mechanistic epidemiological modeling: A scoping review of opportunities and challenges, Nature Communications 2025, 16(1): 1-18
Du Z, Pandey A, Moghadas SM, Bai Y, Wang L, Matrajt L, Singer BH, Galvani AP, Impact of RSVpreF vaccination on reducing the burden of respiratory syncytial virus in infants and older adults, Nature Medicine 2025, 31(2): 647-652.
Shin T, Wells CR, Shoukat A, Potter-Schwartz L, Langevin E, Galvani AP, Moghadas SM, Quadrivalent conjugate vaccine and invasive meningococcal disease in US adolescents and young adults, JAMA Network Open 2024, 7(11): e2443551.
John-Baptiste A, Moulin M, Li Z, Hamilton D, Crichlow G, Eisenkraft Klein D, Alemu FW, Ghattas L, McDonald K, Asaria M, Sharpe C, Pandya E, Moqueet N, Champredon D, Moghadas SM, Cooper L, Pinto A, Stranges S, Haworth-Brockman MJ, Galvani AP, Ali S, Do COVID-19 infectious disease models incorporate the social determinants of health? A systematic review, Public Health Reviews 2024, 45: 1607057.
Ali Z, Li Z, Moqueet N, Moghadas SM, Galvani AP, Cooper LA, Stranges S, Haworth-Brockman M, Pinto AD, Asaria M, Champredon D, Hamilton D, Moulin M, John-Baptiste A. Incorporating social determinants of health in infectious disease models: a systematic review of guidelines. Medical Decision Making, 2024, 44(7): 742-755.